The effectiveness of anti-malarial drugs against the coronavirus will be formally studied in hospitals across the Netherlands from next week, reports NU.nl.
Glenmark was among a wave of drugmakers that decided having U.S. manufacturing was a good hedge when FDA crackdowns on facilities in India were keeping some of them from exporting to the U.S. The Mumbai-based Glenmark will see if that bet pays off when a $100 million plants open in North Carolina on Tuesday.
Europe (Glenmark) has been granted final approval by the MHRA (Medicines and Healthcare products Regulatory Agency) for Maloff Protect (250mg/100mg atovaquone/proguanil film-coated tablets), anti-malarial medication, as a pharmacy license in the United Kingdom.